Filter announcements
Loading...
Unichem Laboratories Ltd is involved in pharmaceuticalsin Generics, APIs and Contract Manufacturing (CMO) areas.
Unichem Laboratories has extended the exercise period for the first and second tranches of vested employee stock options under its 2018 scheme, pushing the deadline to March 31, 2027. All other terms of the grants remain unchanged.
Significant increase in volume has been observed in Unichem Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Unichem Laboratories Limited has...
Unichem Laboratories Limited has submitted the Exchange a copy Srutinizers report of undefined held on August 11, 2026. Further, the company has informed the Exchange regarding voting results.
Unichem Laboratories Limited has informed the Exchange about Copy of Newspaper Publication - Financial Results for the quarter ended June 30, 2026, published in the newspapers on August 12, 2026
Unichem Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 11, 2026